Sheryl F Vondracek

No ORCID on file · 1 paper in corpus
rct 2015
Menopause (New York, N.Y.) ·doi:10.1097/gme.0000000000000430

OBJECTIVE: Suppression of ovarian hormones in premenopausal women on gonadotropin-releasing hormone agonist (GnRH(AG)) therapy can cause fat mass (FM) gain and fat-free mass (FFM) loss. Whether this is specifically caused by a decline in se…